ScopeMVZ genetikum
Official name: MVZ genetikum GmbH
69 capabilities
Accredited since November 2025
Verified May 2026
One of 3,188 in Germany
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
WegenerstraĂźe 15
Neu-Ulm 89231 , Germany
Neu-Ulm 89231 , Germany
Accreditation
Active
DAkkS
D-ML-22061-01-01
Specializes in molecular human genetics and cytogenetics with capability to modify and develop genetic testing procedures, including PCR-based fragment length analysis and Sanger sequencing of blood and DNA samples.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-22061-01-01
Status
ActiveSince
10 November 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFAdditional scope documents
Test Capabilities (69)
| Standard Reference | Description | Category |
|---|---|---|
| Angeborener Chromosomensatz | angeborener Chromosomensatz | Biocompatibility (ISO 10993) |
| AZFa-c | AZFa-c | Biological / Microbiological |
| Druckläsion (HNPP) | Druckläsion (HNPP) | Biological / Microbiological |
| Duchennesche/Beckersche | Duchennesche/Beckersche | Biological / Microbiological |
| Dysplasie (ACH, HCH, TD) | Dysplasie (ACH, HCH, TD) | Biological / Microbiological |
| Glykogenose Typ II (Pompe) | Glykogenose Typ II (Pompe) | Biological / Microbiological |
| Hypochondroplasie, Thanatophore | Hypochondroplasie, Thanatophore | Biological / Microbiological |
| Hämochromatose (H63D, C282Y) | Hämochromatose (H63D, C282Y) | Biological / Microbiological |
| Muskeldystrophie (DMD, BMD) | Muskeldystrophie (DMD, BMD) | Biological / Microbiological |
| Myotone Dystrophie (DM1) | Myotone Dystrophie (DM1) | Biological / Microbiological |
| Schwerhörigkeit (Cx26 ) | Schwerhörigkeit (Cx26 ) | Biological / Microbiological |
| fra(X)-Syndrom | fra(X)-Syndrom | Biological / Microbiological |
| Pränataler PCR Schnelltest: | Pränataler PCR Schnelltest: | Chromatography (GC, HPLC) |
| (kundenspezifisches Gen-Panel) | (kundenspezifisches Gen-Panel) | Elemental Analysis |
| 31 Mutationen im CFTR | 31 Mutationen im CFTR | Elemental Analysis |
| ALK, APC, APOB, AR, ARID1A, ARID1B, ARID2, ATM, ATP7B, ATR, AXIN2, BAP1, BARD1, BLM, BMP15, BMPR1A, BRCA1, BRCA2, BRIP1, BTG4, C11orf80, CACNA1S, CASR, CCND2, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CDKN2B, CEBPA, CFTR, CHEK2, COL3A1, CPA1, CTRC, CYP11B1, CYP17A1, CYP19A1, DDB2, DIAPH2, DICER1, DIS3L2, DMRT1, DPF2, DSC2, DSG2, DSP, EGFR, EPCAM, EPHB4, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, ERCC6, ERCC8, EXT1, EXT2, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FBN1, FGFR1, FH, FIGLA, FLCN, FOXL2, FSHR, GALNT12, GATA2, GLA, GNA11, GNAQ, GNAS, GPC3, GREM1, HDAC8, HFE, HFM1, HOXB13, HRAS, HSD3B2, KCNH2, KCNJ2, KCNQ1, KDM6A, KHDC3L, KIF1B, KIT, KLHL10, KMT2D, KRAS, LDLR, LMNA, LZTR1, M1AP, MAX, MC1R, MCM9, MEI1, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, | ALK, APC, APOB, AR, ARID1A, ARID1B, ARID2, ATM, ATP7B, ATR, AXIN2, BAP1, BARD1, BLM, BMP15, BMPR1A, BRCA1, BRCA2, BRIP1, BTG4, C11orf80, CACNA1S, CASR, CCND2, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CDKN2B, CEBPA, CFTR, CHEK2, COL3A1, CPA1, CTRC, CYP11B1, CYP17A1, CYP19A1, DDB2, DIAPH2, DICER1, DIS3L2, DMRT1, DPF2, DSC2, DSG2, DSP, EGFR, EPCAM, EPHB4, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, ERCC6, ERCC8, EXT1, EXT2, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FBN1, FGFR1, FH, FIGLA, FLCN, FOXL2, FSHR, GALNT12, GATA2, GLA, GNA11, GNAQ, GNAS, GPC3, GREM1, HDAC8, HFE, HFM1, HOXB13, HRAS, HSD3B2, KCNH2, KCNJ2, KCNQ1, KDM6A, KHDC3L, KIF1B, KIT, KLHL10, KMT2D, KRAS, LDLR, LMNA, LZTR1, M1AP, MAX, MC1R, MCM9, MEI1, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, | Elemental Analysis |
| Alpha 1-Antitrypsin-Mangel | Alpha-1-Antitrypsin-Mangel | Elemental Analysis |
| BRCA-Panel; BRCA1, BRCA2 | BRCA-Panel; BRCA1, BRCA2 | Elemental Analysis |
| GLA; Morbus Fabry | GLA; Morbus Fabry | Elemental Analysis |
| Genetikum-Panel | Genetikum-Panel | Elemental Analysis |
| HFE | Hämochromatose --HFE | Elemental Analysis |
| Markerchromosomen-Abklärung | Markerchromosomen-Abklärung | Elemental Analysis |
| Mikrodeletions- und | Mikrodeletions- und | Elemental Analysis |
| Mikroduplikationssyndrome | Mikroduplikationssyndrome | Elemental Analysis |
| NOBOX, NR5A1, NRAS, NSD1, NTHL1, PADI6, PALB2, PANX1, PATL2, PBRM1, PCSK9, PDGFRA, PHOX2B, PIK3CA, PIK3R2, PKP2, PMS1, PMS2, POF1B, POLD1, POLE, POR, POT1, POU6F2, PRKAG2, PRKAR1A, PRSS1, PTCH1, PTCH2, PTEN, PTPN11, RAD21, RAD50, RAD51, RAD51B, RAD51C, RAD51D, RASA1, RASA2, RB1, REC114, RECQL4, REST, RET, RHBDF2, RINT1, RNF43, RUNX1, RYR1, RYR2, SCN4A, SCN5A, SDHA, SDHAF2, SDHB, SDHC, SDHD, SEC23B, SHOC1, SLC35A2, SLX4, SMAD3, SMAD4, SMARCA4, SMARCB1, SMARCC2, SMARCD1, SMARCE1, SMC1A, SMC3, SOX11, SOX4, SPINK1, SPRED1, STAG3, STAR, STK11, SUFU, SYCE1, SYCP2, TERC, TERF2IP, TERT, TEX11, TEX14, TEX15, TGFBR1, TGFBR2, TLE6, TMEM127, TMEM43, TNNI3, TNNT2, TP53, TPM1, TRIP13, TSC1, TSC2, TUBB8, VHL, WEE2, WRN, | NOBOX, NR5A1, NRAS, NSD1, NTHL1, PADI6, PALB2, PANX1, PATL2, PBRM1, PCSK9, PDGFRA, PHOX2B, PIK3CA, PIK3R2, PKP2, PMS1, PMS2, POF1B, POLD1, POLE, POR, POT1, POU6F2, PRKAG2, PRKAR1A, PRSS1, PTCH1, PTCH2, PTEN, PTPN11, RAD21, RAD50, RAD51, RAD51B, RAD51C, RAD51D, RASA1, RASA2, RB1, REC114, RECQL4, REST, RET, RHBDF2, RINT1, RNF43, RUNX1, RYR1, RYR2, SCN4A, SCN5A, SDHA, SDHAF2, SDHB, SDHC, SDHD, SEC23B, SHOC1, SLC35A2, SLX4, SMAD3, SMAD4, SMARCA4, SMARCB1, SMARCC2, SMARCD1, SMARCE1, SMC1A, SMC3, SOX11, SOX4, SPINK1, SPRED1, STAG3, STAR, STK11, SUFU, SYCE1, SYCP2, TERC, TERF2IP, TERT, TEX11, TEX14, TEX15, TGFBR1, TGFBR2, TLE6, TMEM127, TMEM43, TNNI3, TNNT2, TP53, TPM1, TRIP13, TSC1, TSC2, TUBB8, VHL, WEE2, WRN, | Elemental Analysis |
| PTPN11 | PTPN11 | Elemental Analysis |
| Subtelomeranalyse | Subtelomeranalyse | Elemental Analysis |
| WT1, XPA, XPC, XRCC2, XRCC3, ZP2, ZP3 | WT1, XPA, XPC, XRCC2, XRCC3, ZP2, ZP3 | Elemental Analysis |
| Whole Exome Sequenzierung (WES) | Whole Exome Sequenzierung (WES) | Elemental Analysis |
| (GLUT1) | (GLUT1) | Molecular Diagnostics / PCR |
| (Typ Kennedy) | (Typ Kennedy) | Molecular Diagnostics / PCR |
| ADCY5, PNKD, PRRT2, SLC2A1 | ADCY5, PNKD, PRRT2, SLC2A1 | Molecular Diagnostics / PCR |
| Adrenogenitales Syndrom (AGS) | Adrenogenitales-Syndrom (AGS) | Molecular Diagnostics / PCR |
| Angelman Syndrom | Deletion; Angelman-Syndrom | Molecular Diagnostics / PCR |
| Atrophie | Spinobulbäre Muskelatrophie | Molecular Diagnostics / PCR |
| BRCA1 | BRCA1 | Molecular Diagnostics / PCR |
| Brust- und Eierstockkrebs | Familiärer Brust- und Eierstockkrebs | Molecular Diagnostics / PCR |
| CYP21A2 | CYP21A2 | Molecular Diagnostics / PCR |
| Chorea Huntington | HD; Chorea Huntington | Molecular Diagnostics / PCR |
| Chorea Huntington (HD)-HTT | Chorea Huntington (HD)-HTT | Molecular Diagnostics / PCR |
| Cystische Fibrose | Cystische Fibrose: Screening der | Molecular Diagnostics / PCR |
| DMPK | DMPK | Molecular Diagnostics / PCR |
| Ethanolamin, Fortsetzung | Ethanolamin, Fortsetzung | Molecular Diagnostics / PCR |
| FGFR3 | OMIM*176943, FGFR3 | Molecular Diagnostics / PCR |
| GAA | GAA | Molecular Diagnostics / PCR |
| GJB2 | syndromale (DFNB1) [GJB2 | Molecular Diagnostics / PCR |
| GLA | GLA | Molecular Diagnostics / PCR |
| Glukose-Transporter-Defizienz | Glukose-Transporter-Defizienz | Molecular Diagnostics / PCR |
| Hereditäre Neuropathie mit | Hereditäre Neuropathie mit | Molecular Diagnostics / PCR |
| LEOPARD-Syndrom (LPRD1) | LEOPARD-Syndrom (LPRD1) | Molecular Diagnostics / PCR |
| MECP2 | MECP2 | Molecular Diagnostics / PCR |
| Markeranalyse | STR-Markeranalyse | Molecular Diagnostics / PCR |
| MeCP2; Rett-Syndrom | MeCP2; Rett-Syndrom | Molecular Diagnostics / PCR |
| PMP22 | PMP22 | Molecular Diagnostics / PCR |
| Prader Willi Syndrom | Prader-Willi-Syndrom: | Molecular Diagnostics / PCR |
| SHOX | SHOX | Molecular Diagnostics / PCR |
| SHOX-Defizienz | SHOX-Defizienz: Leri-Weill- | Molecular Diagnostics / PCR |
| Smith-Lemli-Opitz-Syndrom (SLOS) | Smith-Lemli-Opitz-Syndrom (SLOS) | Molecular Diagnostics / PCR |
| Spinale Muskelatrophie (SMA) | Spinale Muskelatrophie (SMA): | Molecular Diagnostics / PCR |
| UBE3A | UBE3A | Molecular Diagnostics / PCR |
| Alpha-1-Antitrypsin (SERPINA1- | Alpha-1-Antitrypsin (SERPINA1- | Other |
| DHCR7 | Smith-Lemli-Opitz-Syndrom (DHCR7 | Other |
| DMD | Muskeldystrophie Becker (DMD | Other |
| FMR1 | Tremor-Ataxie-Syndrom (FMR1 | Other |
| Morbus Meulengracht (UGT1A1 | Morbus Meulengracht (UGT1A1 | Other |
| Syndrom), Crigler-Najjar-Syndrom | Syndrom), Crigler-Najjar-Syndrom | Other |
| Azoospermiefaktor | Azoospermiefaktor | Sterility Testing |
| SMN1 | SMN1 | Sterility Testing |
| *) 1 bar; 2 bar | *) 1 bar; 2 bar | Temperature / Pressure |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.